Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy
Longevity Technology - 02-Sep-2025Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
Join the club for FREE to access the whole archive and other member benefits.
Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Startup uses AI to explore billions of molecules for next-gen skincare innovation
New DeSci platform uses tokens and AI to speed breakthroughs in ageing research
Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Click on resource name for more details.
12-Mar-2026
One-day conference for over 350 visitors focused on AI, cybersecurity, and big data (St. Gallen, Switzerland)
Translating Aging podcast episode- Chris and Sergey discuss how investment strategies are driving the future of longevity biotech
22-Sep-2025
Conference gathering longevity experts and investors at one place (Gstaad, Switzerland)
30-Aug-2025
Opportunity to invest in longevity with investors, longevity entrepreneurs, scientists and policy makers (Aix-en-Provence, France)
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science